COMPANY PROFILE

Cofactor Genomics

Explore full profile

Cofactor Genomics uses RNA to diagnose disease

St. Louis, United StatesFounded 2008Biotech & Life Sciences

Valuation $50–100M Last recorded · 2017

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Cofactor Genomics

Cofactor Genomics specializes in precision medicine by leveraging RNA sequencing and advanced machine learning algorithms to develop multidimensional models of disease. The company focuses on identifying powerful biomarkers that can predict patient responses to treatments, particularly in the field of immunotherapy. Operating in the biotechnology and healthcare sectors, Cofactor Genomics serves pharmaceutical companies, research institutions, and clinical laboratories. Its business model revolves around providing RNA profiling services and predictive immune modeling solutions, which are critical for developing personalized treatment plans. Revenue is generated through service contracts, clinical study collaborations, and partnerships with healthcare providers.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2008
Headquarters: St. Louis, United States
Employees: 12
Open positions: None listed
Dealroom signal: 76.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Analytics, Biotechnology, DNA, Genetics and genomics
Technology: Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Nanotech
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Dec 2025	$0	—	LabCorp · Ascension	↗
EARLY VCEquity / VC	Dec 2021	$6.9M	$28M	Undisclosed	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Cofactor Genomics website traffic

Latest recorded traffic for Cofactor Genomics is 2.8K monthly website visits, down 22.2% over the last three months. Cofactor Genomics's team grew 9.1% over the past year.

Latest monthly visits2.8K 3-month web change-22.2% 1-year team growth+9.1%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
DGDeep GenomicsDeep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies	Toronto, Canada	Operational	112	$237M	$720M
INInivataClinical cancer genomics company harnessing the emerging potential of circulating DNA analysis	Morrisville, United States	Acquired
FGFabric GenomicsGlobal healthcare platform for genomic data analysis - Formerly Omicia	San Francisco, United States	Acquired
PRPreneticsAims to give millions of people personalized information about the health of their bodies to help them confidently make choices about their lives	Eastern District, Hong Kong	Operational
HEHelixThe leading population genomics company working at the intersection of clinical care, research, and genomics	San Mateo, United States	Operational
TGTransplant GenomicsBiotech company that focuses on improving organ transplant outcomes	Los Angeles, United States	Operational
VGVeritas GeneticsDelivering on the promise of the human genome, empowering people to maximize quality and length of life for themselves and their families	Danvers, United States	Acquired
VAVacunekVacunek is engaged in the development and application of innovative biotechnologies in the animal health sector	Eindhoven, Netherlands	Closed